Total national coverage footprint for PENFS increases to over 120 million covered lives

CARMEL, Ind., Sept. 16, 2026 (GLOBE NEWSWIRE) — NeurAxis, Inc. (“NeurAxis” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today announced significant new medical policy coverage from a major national health insurer for Percutaneous Electrical Nerve Field Stimulation (“PENFS”). The coverage spans multiple states and represents approximately 18 million health plan members.

NeurAxis’ proprietary PENFS technology, IB-Stim, is FDA-cleared for the treatment of functional abdominal pain associated with irritable bowel syndrome (IBS) and Functional Dyspepsia (FD) including associated nausea symptoms in patients 8 years and older. IB-Stim is a non-invasive neuromodulation device that gently stimulates cranial nerve bundles in the ear to help regulate pain signaling between the gut and the brain. Currently, no FDA-approved drug therapies exist for pediatric patients with abdominal pain related to functional dyspepsia, a significant unmet medical need. In the absence of approved options, off-label prescription drugs are often used, despite limited efficacy data and potential safety concerns—underscoring IB-Stim’s unique position as the only FDA-cleared therapy specifically designed for this large and underserved pain related patient population.

“NeurAxis’ growth is accelerating as we execute on our plans to expand payer coverage, broaden patient access and scale commercialization of IB-Stim,” said Brian Carrico, Chief Executive Officer of NeurAxis. “Securing medical policy coverage for PENFS from one of the nation’s leading health insurers demonstrates tangible progress against these priorities. We are translating our clinical evidence into meaningful coverage gains and actively pursuing additional major national insurers to build on this momentum.

“With a Category I CPT code effective January 1, 2026, and our proprietary PENFS technology incorporated into leading national society clinical practice guidelines, we have established a strong foundation to support continued growth. Our focus is now on converting these achievements into broader physician adoption, increased patient access and sustained commercial expansion. Backed by a strengthened balance sheet and growing payer recognition, we believe NeurAxis is well positioned to deliver significant revenue growth and margin expansion as we continue executing on our strategy.”

About NeurAxis, Inc.

NeurAxis, Inc., is a medical technology company focused on neuromodulation therapies to address chronic and debilitating conditions in children and adults. NeurAxis is dedicated to advancing science and leveraging evidence-based medicine to drive the adoption of IB-Stim, its proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology, by the medical, scientific, and patient communities. IB-Stim is FDA-cleared for functional abdominal pain in irritable bowel syndrome (IBS) and functional dyspepsia, including FD-linked nausea symptoms in patients ages 8 and older. Additional clinical trials of PENFS in multiple pediatric and adult conditions with large unmet healthcare needs are underway. For more information, please visit http://neuraxis.com.

Forward-Looking Statements

Certain statements in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are forward-looking statements. Forward-looking statements are based on management’s current assumptions and expectations of future events and trends, which affect or may affect the Company’s business, strategy, operations or financial performance, and actual results and other events may differ materially from those expressed or implied in such statements due to numerous risks and uncertainties. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. There are a number of important factors that could cause actual results, developments, business decisions or other events to differ materially from those contemplated by the forward-looking statements in this press release. These factors include, among other things, the conditions in the U.S. and global economy, the trading price and volatility of the Company’s stock, public health issues or other events, the Company’s compliance with applicable laws, the results of the Company’s clinical trials and perceptions thereof, the results of submissions to the FDA, and factors described in the Risk Factors section of NeurAxis’s public filings with the Securities and Exchange Commission (SEC). Because forward-looking statements are inherently subject to risks and uncertainties, you should not rely on these forward-looking statements as predictions of future events. These forward-looking statements speak only as of the date of this press release and, except to the extent required by applicable law, the Company undertakes no obligation to update or revise these statements, whether as a result of any new information, future events and developments or otherwise.

For contraindications, precautions, warnings, and IFU, please see: https://ibstim.com/important-information/.

For important RED information, including indications, precautions, and contraindications, visit: https://red4constipation.com/information/

Contacts:

Company
NeurAxis, Inc.
info@neuraxis.com

For contraindications, precautions, warnings, and IFU, please see: https://ibstim.com/important-information/.

Investor Relations
Lytham Partners
Ben Shamsian
646-829-9701
shamsian@lythampartners.com

Amid rising prices, holiday shoppers are tuning out ads and turning to social earlier for savings, according to new data from Sprout Social

CHICAGO, Sept. 16, 2026 (GLOBE NEWSWIRE) — According to new research from Sprout Social (NASDAQ: SPT), a leading AI-powered Social Intelligence platform, holiday shoppers are taking a more intentional approach to seasonal spending this year and relying on social media throughout their shopping experience. Amid tariff concerns and rising prices, Sprout Social’s Q3 2026 Pulse Survey finds consumers are shopping earlier, seeking discounts, and prioritizing useful social content over targeted ads.

With more than half of consumers (56%) planning to reduce holiday spending because of broader economic conditions, shoppers are looking to make their budgets go further. Nearly 7 in 10 consumers (69%) are concerned about tariff-related price increases, and 36% say they plan to start shopping earlier specifically to avoid them. For brands, that doesn’t mean simply moving holiday campaigns up; it means earning shopper consideration sooner.

Social media is increasingly influencing purchasing decisions, which makes it a critical place to earn attention this holiday season. It has caught up to physical stores, tying as the leading destination for gift discovery among all consumers (46%) and emerging as the clear #1 place for Gen Z to discover products (54%). Social’s role extends beyond discovery and into a purchase platform, as 57% of consumers are open to purchasing directly within social apps.

The research also shows that consumers are looking for more useful content, like a deal or a product demonstration, rather than an influx of brand messaging. Promo codes shared by a company or an influencer are the top driver of holiday purchases followed by posts showing a product in action, while targeted social ads are the least effective driver.

“Because of a tighter economic climate, every purchase carries more weight, making it critical for brands to refine their messaging to ensure it is thoughtful and grounded,” said Scott Morris, CMO at Sprout Social. “As marketers conduct final check-ins on their holiday campaigns, there is a real opportunity to bring alignment across every channel. Brands can support creator partners by encouraging them to keep education and utility at the forefront of their content, while preparing care teams for fast responses. Our data shows shoppers are using social for their entire holiday journey, and delivering genuine utility across that total presence helps brands maximize their ROI while building lasting trust.”

Consumers are closing out their shopping journey on social by heading to platforms like TikTok (50%), Facebook (46%) and Instagram (44%) for customer service, and using direct messages as their preferred way to contact a brand (55%). To meet high expectations for customer care speed, 70% of consumers are comfortable with brands using AI-powered tools to deliver faster responses.

Beyond seasonal shopping, the Q3 2026 Pulse Survey highlights social media’s role in other timely events like upcoming elections:

  • A new newsstand: Ahead of the 2026 midterms, social media serves as a primary news source, standing as the #1 channel for Millennials (38%) and Gen Z (33%).
  • Politicians as influencers: Social posts from politicians have real influence with 55% of all consumers citing that a social post has informed or changed their opinion, while over half of Gen Z report actually changing their mind on an issue.
  • Candidate followings: 45% of social users say they do not follow any politician on social media. Just over a quarter (26%) follow 1-2 politicians.
  • Deepfake concerns: During the election cycle, 84% of voters are concerned about encountering AI-generated deepfakes on social platforms.

For more, including sentiment towards AI disclosure and how brands show up alongside online culture, access the full Q3 2026 Pulse Survey here.

About the data

This consumer survey was conducted online by Glimpse, a global market research firm, on behalf of Sprout Social. Participants included 2,286 social media users across the US, UK and Australia. The survey was conducted from August 11 2026 to August 18 2026.

About Sprout Social

Sprout Social is a leading AI-powered Social Intelligence platform, built on the belief that All Business is Social℠. Powered by Trellis, Sprout’s proprietary AI agent, the platform transforms real-time social media signals into actionable insights that drive business forward. Consistently recognized as a top software by G2, Sprout enables brands to deliver smarter, faster business impact through a suite of solutions including comprehensive publishing and engagement, customer care, influencer marketing, advocacy and predictive media intelligence. Sprout’s software operates across all major social networks and digital platforms. For more information about Sprout Social (NASDAQ: SPT), visit sproutsocial.com.

Social Media Profiles
www.x.com/SproutSocial
www.x.com/SproutSocialIR
www.facebook.com/SproutSocialInc
www.linkedin.com/company/sprout-social-inc-/
www.instagram.com/sproutsocial

Media Contact
Kaitlyn Gronek
Email: pr@sproutsocial.com
Phone: (773) 904-9674

All financial figures are in Canadian dollars.

CALGARY, Alberta, Sept. 16, 2026 (GLOBE NEWSWIRE) — Gibson Energy Inc. (“Gibson” or the “Company”), (TSX: GEI), announced today the renewal of its Normal Course Issuer Bid (“NCIB”).

The Toronto Stock Exchange (the “TSX”) has accepted Gibson’s notice of intention to commence its NCIB for an additional one-year period. This enables the Company to purchase and cancel up to 7,251,988 common shares, representing 5% of the Company’s public float as of September 4, 2026, over the 12-month period commencing September 18, 2026, in accordance with the applicable rules and policies of the TSX and applicable securities laws. As of September 4, 2026, the Company had 172,561,791 common shares issued and outstanding.

Under the NCIB, common shares may be repurchased in open market transactions on the TSX, and/or other Canadian alternative trading platforms. In accordance with the rules of the TSX governing an NCIB, the total number of common shares the Company is permitted to purchase is subject to a daily purchase limit of 202,097 common shares, representing 25% of the average daily trading volume of 808,390 common shares on the TSX calculated for the six-month period ended August 31, 2026. The NCIB will terminate at the earlier of September 17, 2027 and the date on which the maximum number of common shares that can be acquired pursuant to the NCIB has been purchased.

The price that Gibson will pay for common shares in open market transactions will be the market price at the time of purchase. Gibson continues to believe that the availability of an NCIB will enable the Company to maximize return to shareholders. The actual number of common shares that may be purchased, if any, and the timing of any such purchases, will be determined by Gibson based on several factors, including the continued adherence to its financial principles. Gibson has not purchased any common shares under its normal course issuer bid that commenced on September 18, 2025 and will end on September 17, 2026 (the “Prior NCIB”). 10,182,288 common shares were approved for purchase under the Prior NCIB.

The Company expects to enter into an automatic purchase plan with its broker, BMO Nesbitt Burns Inc., to facilitate purchases of its common shares. The automatic purchase plan allows for purchases by the Company of its common shares at any time, including, without limitation, when the Company would ordinarily not be permitted to make purchases due to regulatory restriction or self-imposed blackout periods. Purchases will be made by Gibson’s broker based upon the parameters prescribed by the TSX and the terms of the parties’ written agreement.

About Gibson
Gibson is a leading liquids infrastructure company providing storage, optimization, processing, gathering, and waterborne vessel loading services for liquids and refined products. Headquartered in Calgary, Alberta, the Company’s operations are located across North America, with core terminal assets in Hardisty and Edmonton, Alberta, Ingleside and Wink, Texas, and a facility in Moose Jaw, Saskatchewan.

Gibson shares trade under the symbol GEI and are listed on the Toronto Stock Exchange. For more information, visit www.gibsonenergy.com.

Forward-Looking Statements
Certain statements contained in this news release constitute forward-looking information and statements (collectively, “forward-looking statements”) including, but not limited to, statements concerning the NCIB, common shares which may be purchased under the NCIB and related matters. All statements other than statements of historical fact are forward-looking statements. The use of any of the words “anticipate”, “expect”, “may”, “will”, “can”, “should”, “would”, “plan”, “intend”, “believe”, “target” and similar expressions are intended to identify forward looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. No assurance can be given that these expectations will prove to be correct and such forward-looking statements included in this news release should not be unduly relied upon. These statements speak only as of the date of this news release. The Company does not undertake any obligations to publicly update or revise any forward-looking statements except as required by securities law. Actual results could differ materially from those anticipated in these forward-looking statements as a result of numerous risks and uncertainties including, but not limited to, the risks and uncertainties described in “Forward-Looking Statements“ and “Risk Factors” included in the Company’s Annual Information Form dated February 17, 2026 and Management’s Discussion and Analysis, dated July 27, 2026, as filed on SEDAR+ and available on the Gibson website at www.gibsonenergy.com.

For further information, please contact:

Investor Relations
(403) 776-3077
investor.relations@gibsonenergy.com

ibex Wave iX Virtual Agent Honored for Exceptional Innovation

Globee Awards Winner

ibex Wins 2026 Globee Award for AI-Powered Customer Experience Solution Excellence
ibex Wins 2026 Globee Award for AI-Powered Customer Experience Solution Excellence

WASHINGTON, Sept. 16, 2026 (GLOBE NEWSWIRE) — ibex (NASDAQ: IBEX), a global leader in outsourced business services and AI-powered customer experience solutions, today announced it was named a winner in the 13th Annual 2026 Globee® Awards for Excellence.

ibex was recognized with the Silver Globee® for its Wave iX Virtual Agent, the industry-leading conversational AI agent for voice and chat that automates customer interactions while increasing resolution rates and customer satisfaction. It delivers AI-driven, brand-aligned voice and text experiences that are human-like, hyper-personalized, and scalable, seamlessly integrating with human agent support systems to enable fast escalation and efficient resolution of complex issues.

“We are proud to accept this recognition from the Globee® Awards, which reflects ibex’s market leadership in leveraging Al to optimize both the customer and agent lifecycles,” said Julie Casteel, Chief Strategic Accounts Officer and CMO at ibex. “With Wave iX, we’re helping organizations connect AI, human expertise, and business insights across the entire customer journey to deliver faster resolutions, more personalized interactions, and measurable business outcomes.”

The Globee® Awards for Excellence recognize achievements across a wide range of categories, reflecting accomplishments in areas such as business performance, operational excellence, leadership, customer success, innovation, and organizational impact across industries. Nominations are evaluated across local, regional, and global achievements, ensuring that impactful work at every level is recognized.

San Madan, President of the Globee Awards, commented: “Congratulations to the 2026 winners for their achievements across diverse areas of business and industry. Your work reflects a commitment to excellence and continued progress across organizations worldwide.”

About ibex

ibex is a global leader in outsourced business services and AI-powered customer experience solutions, enabling the world’s best brands to deliver truly differentiated experiences for their customers. Leveraging a global team of more than 36,000 human CX experts – powered by the best AI technology, decades of CX innovation, and deep business insights – ibex engineers seamless, end-to-end customer journeys from AI agents to human agents at scale across retail, e-commerce, healthcare, fintech, utilities, technology, logistics, and more. Discover more at ibex.co and connect with us on LinkedIn.

About the Globee® Awards

The Globee® Awards, a business awards program with worldwide participation, organize 10 awards programs that recognize achievements across multiple industries and sectors. These include programs focused on business, artificial intelligence, cybersecurity, leadership, innovation, customer excellence, technology, and more. To learn more about the Globee® Awards, visit: https://globeeawards.com

Media Contact
Dan Burris
Ibex
Daniel.Burris@ibex.co

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/32af2717-cca8-42cc-9f4b-e75c36ac63f1

Successful Paid Pilot Conversion Further Highlights Cross-Sell Opportunity Across Marchex’s Current Customer Base

SEATTLE, Sept. 16, 2026 (GLOBE NEWSWIRE) — Marchex, Inc. (NASDAQ: MCHX) (“Marchex” or the “Company”), a vertically focused, AI-driven conversation analytics, customer acquisition and optimization company, today announced that an advertising and media customer has expanded its relationship with Marchex through the commercial deployment of the Company’s conversational AI Voice Agent solution following a successful paid pilot program.

During the pilot, the AI Voice Agent qualified prospective customers when sales representatives were unavailable, improving call handling and helping the customer capture additional sales opportunities that might have been otherwise missed. The expanded relationship, which currently generates approximately $400,000 in annualized revenue, is expected to generate incremental revenue in 2026 and more than $200,000 in annualized incremental revenue in 2027.

“This expansion demonstrates the opportunity we have to deepen our existing customer relationships with new AI-powered solutions that address measurable business needs,” said Russell Horowitz, Chairman of Marchex. “Our Voice Agent delivered qualified leads when sales representatives were unavailable, creating a clear path from analytics to action and, ultimately, to incremental revenue opportunities for our customer.”

The agreement reflects Marchex’s strategy of expanding analytics relationships through the adoption of additional AI-driven products. “We believe these customer expansions demonstrate the foundation for broader platform growth,” Horowitz added. “As customers adopt additional Marchex AI solutions, their business outcomes improve while increasing the value of our relationship.”

Marchex has signed additional customers for its AI Voice Agent solution and is in discussions with several large enterprise customers on paid pilot programs. If successfully completed and converted to broader commercial deployments, Marchex believes these opportunities could generate significant incremental revenue growth in 2027.

Marchex’s AI Voice Agent helps businesses engage callers through natural, AI-powered conversations. The solution is designed to improve responsiveness, qualify opportunities, and reduce the number of valuable consumer interactions that go unanswered or unaddressed, generally due to employees being unavailable or call volumes exceeding available staffing.

About Marchex

Marchex and Archenia together harness proprietary AI-powered conversational intelligence and advanced customer acquisition technologies to transform consumer intent into actionable, outcome-driven business results. The combination of Marchex’s prescriptive analytics and omnichannel intelligence with Archenia’s AI-verified qualification, natural-language analytics, and automated decisioning capabilities creates a highly differentiated customer acquisition and optimization technology platform. Leveraging real-time AI signals, machine-learning models, and deep vertical market expertise, the company identifies consumer intent, improves qualification accuracy, and delivers verified outcomes such as high-intent conversations, appointments, and sales. Serving market leading companies across major verticals including automotive, insurance, home services, healthcare, and advertising/media, Marchex empowers organizations to optimize customer engagement and drive revenue growth through AI-driven insights, actions, and outcomes.

Please visit www.marchex.com, www.marchex.com/blog, or @marchex on X, where Marchex discloses material information from time to time about the Company, its financial information, and its business.

Forward-Looking Statements

Certain statements included above contain forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, contained herein, including regarding the Company’s strategy and future financial and operational performance, are forward-looking statements, and you should not place undue reliance on such statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in such forward-looking statements due to a number of important factors, which are described in greater detail in the “Risk Factors” section of the Company’s most recent periodic report or registration statement filed with the SEC. All of the information provided herein is as of September 16, 2026 and the Company undertakes no duty to update the information provided herein.

For further information, contact:
Marchex Investor Relations
Email: ir@marchex.com

Angi is part of a select group of brands testing a new conversational advertising experience in ChatGPT

DENVER, Sept. 16, 2026 (GLOBE NEWSWIRE) — Angi (formerly Angie’s List) (NASDAQ: ANGI), a leading digital home services marketplace, today announced it is participating in OpenAI’s Sponsored Agent pilot. The pilot supports Angi’s expansion into emerging AI-powered advertising surfaces, creating a new way to reach homeowners and connect them with skilled local pros.

In this pilot, an Angi-branded sponsored agent may appear in relevant ChatGPT conversations regarding home services. Homeowners will be able to continue the conversation with the Angi agent to share more information about their project and when the job calls for help from a pro, enter Angi’s service request flow to connect with skilled local pros.

“Our AI-first strategy is simple: make it easier for homeowners to connect with and hire the right pro for their project,” said Angie Hicks, co-founder of Angi. “With OpenAI’s Sponsored Agent pilot, homeowners can go directly from discussing a home project in ChatGPT to connecting with a skilled local pro who can help.”

Home services are a high-consideration category, with homeowners often spending significant time researching a project’s scope, urgency and complexity before deciding whether to hire a professional.

The advertising pilot builds on Angi’s existing app in ChatGPT earlier this year, which helps homeowners move from asking a home improvement question to hiring a pro through an AI-guided experience. Unlike the Angi app, which homeowners choose to add in ChatGPT, the Angi-sponsored agent may appear as a clearly labeled sponsored experience within relevant conversations that homeowners can choose to chat with.

To learn more about Angi, visit www.angi.com.

About Angi Inc.
Angi (NASDAQ: ANGI) helps homeowners get home projects done well and helps home service professionals grow their businesses. Founded in 1995, Angi connects homeowners with skilled local professionals, from plumbers and electricians to remodelers and landscapers, and provides tools for researching costs, planning projects and hiring with confidence.Homeowners have turned to Angi, and our vast network of skilled home pros, for help with more than 300 million projects.

Contact Information
Angi Corporate Communications
Jennifer Myers
(303) 963-8352

ASUS validates its leadership in design and innovation with a Bronze Award, plus finalist places for ExpertBook Ultra, ROG XBOX Ally Series, and ROG Zephyrus Duo

KEY POINTS

  • The IDEA awards validate the user-centric ASUS approach and design-thinking philosophy that continuously deliver cutting-edge products
  • Zenbook DUO awarded Bronze in the Consumer Technology category for redefining dual-screen productivity with its innovative design
  • ExpertBook Ultra, ROG XBOX Ally Series, and Zephyrus Duo named finalists for innovation in the Mobility & Gaming category

ASUS Wins Bronze for Zenbook DUO, Plus Three Finalist Spots at 2026 IDEA Awards

TORONTO, Sept. 16, 2026 (GLOBE NEWSWIRE) — ASUS today announced that the Zenbook DUO (2026) (UX8407) laptop won a Bronze Award in the Consumer Technology category at the International Design Excellence Awards (IDEA) 2026. Additionally, three other ASUS products were named as finalists. This distinction reflects the company’s commitment to delivering groundbreaking technologies that enhance users’ lives.

Zenbook DUO secured the Bronze Award for redefining dual-screen productivity with cutting-edge design, while the ExpertBook Ultra, Republic of Gamers (ROG) XBOX Ally Series, and ROG Zephyrus Duo were shortlisted for innovation in the Mobility & Gaming category.

“We are delighted to receive the IDEA Bronze Award, which highlights the team’s pursuit of design excellence,” said Mitch Yang, ASUS Chief Design Officer. “We always strive to create innovative, user-centric technologies that push boundaries and deliver exceptional experiences for users, with our Design Thinking philosophy at the center of every product.”

Zenbook DUO – elegant innovation

The innovation of Zenbook DUO (2026) (UX8407) lies in its seamless dual-screen integration, achieving unprecedented visual continuity in a slender form factor. The detachable keyboard with ‘invisible connectivity’ and the integrated kickstand offer ergonomic flexibility. The proprietary ASUS Ceraluminum™ material provides structural integrity and a unique aesthetic, while the vertical dual-screen mode promotes better posture and redefines mobile productivity.

Zenbook DUO features dual 14-inch 3K OLED 144Hz displays with a minimal 7.66mm gap, integrated via a precision hinge. It includes a detachable Bluetooth® keyboard with a low-friction surface and retractable charging, an integrated kickstand, and is powered by an Intel® Core™ Ultra Series 3 processor. ASUS ScreenXpert software enhances its dual-screen functionality with advanced gestures.

Three ASUS products named as finalists

Among the IDEA 2026 finalists were the ExpertBook Ultra business laptop, the ROG Zephyrus Duo (2026) gaming laptop, and the ROG XBOX Ally series of gaming handhelds. ExpertBook Ultra enables uninterrupted focus through its powerful, silent operation and long-term reliability against daily wear. Dongle-free connectivity and a clutter-free workspace ensure seamless productivity. Enhanced comfort comes from reduced glare, which minimizes sensory fatigue and makes extended use more pleasant.

The ROG Zephyrus Duo delivers genuine dual-monitor productivity anywhere, streamlining complex workflows for gaming, editing, or AI tasks with an expansive digital canvas. Its adaptive workflows, offering five usage modes, cater to diverse scenarios, while the detachable keyboard and consolidated workspace provide ergonomic flexibility and a powerful, portable solution.

The ROG XBOX Ally series’ ergonomic design and optimized weight ensure superior comfort and reduce fatigue for users. It lets users experience faster, smoother, and more immersive desktop-class PC gaming anywhere, thanks to a streamlined OS, optimized resource allocation, and precise controls, all within a sustainable design that minimizes environmental impact.

About IDEA

IDEA is organized by the Industrial Designers Society of America (IDSA). The 46th iteration of the award winners was announced on August 27, 2026, and it is one of the longest-running and most prestigious design award programs. IDEA winners are determined through blind evaluation by a jury of experts who assess thousands of entries based on design innovation, benefits to users, clients, and society, and appropriate aesthetics. Further details can be found at: https://www.idsa.org/IDEA

Press Contacts

Redoine Taoussi

Senior Public Relations Manager

Redoine_Taoussi@asus.com

Notes to Editors

ASUS Zenbook DUO (UX8407): https://www.asus.com/ca-en/laptops/for-home/zenbook/asus-zenbook-duo-ux8407/

ASUS ExpertBook Ultra: https://www.asus.com/ca-en/laptops/for-work/expertbook/asus-expertbook-ultra/

ROG Zephyrus Duo: https://rog.asus.com/ca-en/laptops/rog-zephyrus/rog-zephyrus-duo-2026/

ROG XBOX Ally Series: https://rog.asus.com/ca-en/gaming-handhelds/rog-ally-series/

IDEA Awards (IDSA): https://www.idsa.org/IDEA

ASUS Homepage: https://www.asus.com/ca-en/

ASUS AI PCs: https://www.asus.com/ca-en/content/asus-ai-pc/

ASUS Pressroom: http://press.asus.com

ASUS Canada Facebook: https://www.facebook.com/asuscanada/

ASUS Canada Instagram: https://www.instagram.com/asus_ca

ASUS Canada YouTube: https://ca.asus.click/youtube

ASUS Global X (Twitter): https://www.x.com/asus

About ASUS

ASUS (2357.TW) is an innovative technology leader delivering the world’s most comprehensive AI solutions across Infrastructure, Physical AI, AI PC/Devices, and Engineering the AI Advantage. Guided by its “Ubiquitous AI. Incredible Possibilities.” strategy, ASUS is bringing enterprise-to-edge AI to life. The ASUS portfolio also includes the ROG and ProArt sub-brands, which serve gamers and creators worldwide.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/1dcdfbb2-6af2-4adb-bb7d-eca94c73f80e

HOMEWOOD, Ill., Sept. 16, 2026 (GLOBE NEWSWIRE) — CN (TSX: CNR) (NYSE: CNI) Police officers along with other CN spokespeople will be available to members of the media during See Tracks? Think Train® Week from September 21-25, 2026. This annual public awareness campaign highlights the importance of safe behaviours near rail crossings and the danger of trespassing on railway property.

Uniformed CN Police officers and CN spokespeople will be available for interviews across CN’s network in the United States and will take part in community events throughout the week. Media outlets can contact CN’s media relations team to schedule phone, virtual or in-person (where possible) interviews as well as requests visuals to support broadcast, print, and online coverage.

Why Rail Safety Matters
Every year, preventable accidents occur at rail crossings and along railway property. CN’s message is simple: Safety is a shared responsibility. By working together with schools, communities, and media partners, CN aims to reduce incidents and save lives.

See Tracks? Think Train Activities
CN is proud to partner with Operation Lifesaver Inc. and local authorities across North America to deliver a range of online and in-person activities during See Tracks? Think Train® Week. These initiatives promote safe practices, raise awareness about rail crossing safety, and highlight the risks of trespassing on railway property. CN continues to invest in rail safety and invites all communities across its network to participate in See Tracks? Think Train® Week activities.

About CN Police
Every year, CN Police Services respond to hundreds of events across the eight Canadian provinces and 16 U.S. states within our network. In addition to protecting CN property, CNPS officers deliver rail safety presentations to schools, trucking agencies, bus operators and community organizations. By rolling out strategic educational initiatives and conducting targeted operations, CNPS aims to promote safe behaviors and increase awareness of rail safety. CNPS is committed to making CN the safest railroad in North America.

For more information or to schedule an interview with a CN Police Officer, please contact:

US
Canada

MONTREAL, Sept. 16, 2026 (GLOBE NEWSWIRE) — CN (TSX: CNR) (NYSE: CNI) Police officers along with other CN spokespeople will be available to members of the media during Rail Safety Week from September 21-25, 2026. This annual public awareness campaign highlights the importance of safe behaviours near railway crossings and the danger of trespassing on railway property.

Uniformed CN Police officers and CN spokespeople will be available for interviews across Canada and will take part in community events throughout the week. Media outlets can contact CN’s media relations team to schedule phone, virtual or in-person (where possible) interviews as well as requests visuals to support broadcast, print, and online coverage.

Why Rail Safety Matters
Every year, preventable accidents occur at rail crossings and along railway property. CN’s message is simple: Safety is a shared responsibility. By working together with schools, communities, and media partners, CN aims to reduce incidents and save lives.

Rail Safety Week Activities
CN is proud to partner with Operation Lifesaver and local authorities across North America to deliver a range of online and in-person activities during Rail Safety Week. These initiatives promote safe practices, raise awareness about rail crossing safety, and highlight the risks of trespassing on railway property. CN continues to invest in rail safety and invites all communities across its network to participate in Rail Safety Week activities.

About CN Police
Every year, CN Police Services respond to hundreds of events across the eight Canadian provinces and 16 U.S. states within our network. In addition to protecting CN property, CNPS officers deliver rail safety presentations to schools, trucking agencies, bus operators and community organizations. By rolling out strategic educational initiatives and conducting targeted operations, CNPS aims to promote safe behaviours and increase awareness of rail safety. CNPS is committed to making CN the safest railroad in North America.

For more information or to schedule an interview with a CN Police Officer, please contact:

Alberta
Atlantic
British Columbia
Manitoba
Ontario
Quebec
Saskatchewan
Canada

KRTL outlines how expanded regulatory leadership expects to support its developing South American API, botanical, controlled substance, and pharmaceutical strategy

Lakewood, CO, Sept. 16, 2026 (GLOBE NEWSWIRE) — KRTL Holding Group Inc. (OTC: KRTL) (“KRTL” or the “Company”) today outlined how KRTL Biotech Inc. intends to apply its expanded regulatory leadership to the Company’s developing South American pharmaceutical API, controlled-substance, botanical-drug, research, and regulatory-services strategy.

Justin Abril, KRTL Biotech’s President-Designate and Strategic Regulatory & API Consultant, https://krtlbiotech.com/team/justin-abril, brings more than a decade of experience in federal controlled-substance compliance, Schedule I manufacturing, DEA regulatory affairs, and pharmaceutical quality systems. His experience is expected to support KRTL’s developing API, controlled-substance, botanical-drug, and regulatory initiatives.

KRTL believes that developing international pharmaceutical supply relationships requires more than identifying compounds, suppliers, laboratories, or manufacturers. Prospective opportunities must be evaluated against regulatory, quality, security, documentation, analytical, manufacturing, import, and downstream-development requirements before they can be considered for a U.S. pharmaceutical pathway.

Developing a South American API Qualification Pathway

KRTL is evaluating and developing prospective South American relationships involving pharmaceutical APIs, botanical-derived materials, laboratories, technical capabilities, and manufacturing partners. These capabilities are not represented as currently qualified, licensed, or commercially API-ready for any U.S. program. KRTL intends to advance selected opportunities through technical, quality, regulatory, contractual, and commercial diligence before they are considered for U.S. pharmaceutical development or importation.

Abril will help KRTL build the regulatory and qualification framework used to evaluate prospective facilities, API manufacturers, laboratories, botanical sources, research organizations, and technical partners.

• API and CMC documentation and development readiness.
• cGMP manufacturing and pharmaceutical quality systems.
• Analytical testing, specifications, and quality controls.
• Supplier, facility, and partner qualification.
• Supply-chain integrity, traceability, and change-control expectations.
• U.S. import eligibility and appropriate importer pathways.
• DEA registration scope, controlled-substance drug codes, quotas, and import/export authority where applicable.
• Controlled-substance security, storage, recordkeeping, and inventory accountability.
• Applicable FDA, state, institutional, and foreign-country requirements.
• Qualified U.S. research, manufacturing, development, and commercialization partners.
“As we develop prospective relationships in South America, our objective is to determine which opportunities can realistically progress into compliant U.S. pharmaceutical programs,” said Cesar Herrera, Chief Executive Officer of KRTL Biotech Inc. “Justin will help us establish the regulatory, quality, and partner-qualification framework needed to evaluate those opportunities systematically.”

Supporting KRTL’s Coca-Derived Pharmaceutical and API Strategy

KRTL has developed two coca-derived extract platforms, Rayel and Periko. Company records include a TTB formula approval record for Rayel Decocainized Natural Coca Extract, providing an existing regulatory foundation for its applicable beverage-facing use. Together, the two extracts provide KRTL with multiple pathways to evaluate across commercial, analytical, formulation, API, and pharmaceutical applications.

Abril’s experience in Schedule I manufacturing, controlled-substance compliance, pharmaceutical quality systems, DEA regulatory affairs, and regulated supply chains is expected to help KRTL advance these existing assets through the appropriate regulatory and development pathways. His role is expected to include supporting qualification, quality and documentation requirements, CMC readiness, import/export planning, and identification of qualified operating and development partners.

Any coca-derived pharmaceutical or API program would remain subject to applicable DEA, FDA, state, foreign-government, customs, quality, security, and institutional requirements.

Broader Controlled-Substance and Psychedelic Research Opportunities

KRTL also intends to evaluate opportunities involving controlled botanical-drug development, pharmaceutical APIs, Schedule I research, psychedelic compounds, formulation development, analytical testing, CMC development, and institutional research collaborations.

Potential collaborators may include appropriately authorized universities, researchers, laboratories, manufacturers, CROs, clinical sites, importers/exporters, and other qualified institutions. Any such work would remain subject to the activity-specific legal and regulatory requirements applicable to the responsible operating entities.

Extending Regulatory Expertise into Third-Party Consulting Services

KRTL also expects the regulatory infrastructure being developed internally, to support the evaluation and qualification of suppliers, manufacturers, laboratories and collaborators, and, where appropriate, to support qualified third parties engaged in similar categories of pharmaceutical and controlled-substance activity that KRTL is developing. The contemplated services may include registration-readiness, facility and security planning, SOP and recordkeeping support, quota and ARCOS compliance support where applicable, import/export pathway planning, inspection readiness, supplier and facility qualification, and related cGMP and quality-system consulting.

This capability is intended to complement KRTL’s internal development programs by applying the same regulatory, quality, security, and compliance disciplines to third-party engagements. KRTL Biotech would provide advisory, readiness, documentation, and strategic support; responsibility for applications, regulated activities, and government authorizations would remain with the applicable applicant or authorized operating entity.

From Opportunity Identification to Regulatory Qualification

KRTL views Abril’s addition as part of a broader effort to strengthen the regulatory, quality, technical, institutional, manufacturing, and advisory framework used to evaluate pharmaceutical programs and support qualified third-party engagements. The Company intends to develop a repeatable diligence and qualification process that can be applied across multiple API, botanical, controlled substance, research, and consulting initiatives.

“The objective is to understand the pathway before significant resources are committed,” Herrera said. “That means identifying the regulatory requirements, qualifying the right partners, understanding the facility and quality gaps, and determining what is needed to move a viable opportunity into a legitimate development program.”

Neither Abril’s appointment nor KRTL’s current development activities should be interpreted as evidence that any South American facility, controlled-substance program, API, pharmaceutical product, DEA registration, quota, import authorization, FDA submission, or research program has received regulatory approval or is commercially operational unless specifically disclosed by the Company.

About KRTL Biotech Inc.

KRTL Biotech Inc. is a wholly owned subsidiary of KRTL Holding Group Inc. focused on pharmaceutical, biotechnology, active pharmaceutical ingredient (API), botanical, regulatory, research, and commercialization opportunities in the United States and international markets. KRTL Biotech maintains federal registrations and entity identifiers with the U.S. Food and Drug Administration and SAM.gov, including SAM.gov UEI ULPJWZWBM9L5 and CAGE Code 109P9. These registrations and identifiers support the Company’s developing pharmaceutical, regulatory, research, government-contracting, and commercialization activities and do not, by themselves, constitute FDA approval of any specific product, DEA authority, or authorization for any specific controlled-substance activity.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of applicable securities laws. Forward-looking statements include statements regarding anticipated executive roles, pharmaceutical and API strategies, controlled substance and psychedelic research initiatives, regulatory activities, partner qualification, research collaborations, manufacturing relationships, import/export pathways, financing, commercialization, and future operations. Forward-looking statements involve risks and uncertainties, and actual results may differ materially from those expressed or implied. There can be no assurance that contemplated regulatory registrations, permits, quotas, research approvals, import/export authorizations, manufacturing arrangements, institutional collaborations, pharmaceutical development programs, financing, or commercialization activities will be obtained or completed. Neither KRTL Holding Group Inc. nor KRTL Biotech Inc. represents that any compound, API, pharmaceutical product, manufacturing facility, research program, controlled-substance activity, DEA registration, quota, drug code, FDA submission, import authorization, or other regulated activity discussed herein has received regulatory approval unless specifically stated otherwise.

CONTACT: www.krtlholding.com
info@krtlholding.com

Contact: 855-KRTL-HLD


www.krtlbiotech.com
info@krtlbiotech.com

www.krtl-icc.com
info@krtl-icc.com

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.